Form D · Biotechnology
GreenMark Biomedical Inc.
East Lansing, MI · CIK 0001741718
Offering snapshot reported Apr 14, 2026 · SEC filing
- Reported sold
- Yet to sell Offering amount: $5M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 14, 2026 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jan 21, 2025 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Oct 31, 2022 | Initial | $500,000 | No comparison | 3 | SEC filing |
| Jul 17, 2020 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Mar 19, 2019 | Amendment | $1,200,000 | $1,015,000vs May 24, 2018 | 0 | SEC filing |
| May 24, 2018 | Initial | $185,000 | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-580408
Source: Form D, filed Apr 14, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steven Bloembergen | Director, Executive |
| Steven Bloembergen Ph D | Director, Executive |
| Steven Bloembergen, Ph D | Director, Executive |
| Steven Bloembergen, Ph.D. | Director, Executive |
| Joerg Lahann, Ph D | Director |
| Joerg Lahann, Ph.D. | Director |
| Joerg La Hann, Ph.D. | Director |
| Kenneth Pienta | Director |
| Kenneth Pienta, M.D. | Director |
| Michael Snyder | Director |
| Frank Van Luttikhuizen | Director |
| Frank Van Luttikhuizen, Cpa | Director |
| Jeff Wesley | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
325 E. Grand River Avenue Suite 314
East Lansing, MI, 48823-4375
East Lansing, MI, 48823-4375